noted that peripheral blood mononuclear cells (PBMCs) in ovarian cancer patients exhibit significantly higher CA125 binding compared to healthy donors, providing key insights for the development of new diagnostic markers for ovarian cancer (136). This evidence concerns the gene MUC16 and ovarian carcinoma.